A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price increases after President Donald Trump rescinded a 2022 executive order on prescription drug prices has been shared online as authentic.

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe Biden on lowering prescription drug costs in posts online that suggest President Donald Trump has canceled the $35 insulin co-pay cap for certain Medicare programs.

After Natalie Cochran poisoned her husband, she told friends she would let him "sleep it off" instead of taking him to the hospital, prosecutors said.

Researchers explore the impact of exercise on the short-term regulation of insulin pathways in brain circuits.

Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers following its 2018 lawsuit over unaffordable prices that led several diabetics to ration their medications with fatal consequences.

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly out-of-pocket price cap, which is set by law.

Minnesota Attorney General Keith Ellison on Monday will share a major development in his lawsuit against three of the biggest insulin manufacturers. Ellison first accused the companies of deceptive pricing back in 2018. Now, Minnesotans are paying less for insulin — depending on where they’re buying it from.

President Donald Trump voided an executive order signed by former-President Joe Biden aimed at lowering prescription drug prices.

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a rise in generic options. In

The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk deceptively priced its insulin.